COMMUNIQUÉS West-GlobeNewswire

Opthea Granted Japanese Patent Covering OPT-302
29/01/2019
MELBOURNE, Australia, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT) is pleased to announce the grant of Japanese Patent Number 6408492 covering its OPT-302 soluble VEGFR-3 (sVEGFR-3) ‘trap’ molecule. The [...]
SoldierStrong Donates State-of-the-Art Exoskeleton to the Veterans Affairs North Texas Health Care System
29/01/2019
DALLAS, Jan. 29, 2019 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit organization dedicated to providing advanced medical technologies to veterans, donated an Indego Therapy exoskeleton to the Veterans Affairs [...]
Diamond CBD Presents Its Popular CBD Products to CVS Health
29/01/2019
Passage of the farm bill and other local governmental actions have more retailers considering ways to meet the consumers' CBD needs FT LAUDERDALE, Fla., Jan. 29, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE - Diamond CBD [...]
Travelan® FY19 1st Half Update and Geographic Expansion into North America
29/01/2019
Key Highlights: Immuron achieved 7% YoY growth in worldwide sales for the first half of FY19. In the US, Travelan® exhibited double-digit growth for this period, with sales 10% higher than observed for the same time [...]
Transactions in relation to share buyback program
29/01/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Generex Biotechnology Announces Investor Conference Call Scheduled for February 26, 2019
29/01/2019
Management to Provide Details on NuGenerex Immuno-Oncology: Dividend, New Acquisitions, IP Licensing Opportunities, and Strategic Plans for Public Listing Acquisition, Integration of Fuse Medical, Pantheon Medical, and [...]
New U.S. Patent Issuance Granted to AXIM® Biotechnologies for Oral Care Composition Containing Cannabinoids
29/01/2019
NEW YORK, Jan. 29, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (“AXIM® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that the United States Patent [...]
Canada's Marijuana Retail Landscape and Some of the Biggest Players Involved
29/01/2019
VANCOUVER, British Columbia, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Following the 3-month anniversary of marijuana’s legalization in Canada, analysts and consumers alike are wondering what’s next for Canada’s marijuana [...]
Orion Biotechnology Canada report that IND- enabling studies evaluating the safety of their OB-002H microbicide gel have shown an excellent mucosal safety profile
29/01/2019
OTTAWA, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced preclinical data evaluating the safety of OB-002H (5P12-RANTES) which is being [...]
Arch Biopartners Closes Convertible Note Financing
29/01/2019
TORONTO, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced it has closed the non-brokered, unsecured convertible note (“Note”) financing [...]
Marrone Bio Innovations to Host Virtual Roadshow Webinar on February 12th at 8:30 a.m. Pacific Time
29/01/2019
DAVIS, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII ), an international leader in smart biopesticide and plant health solutions, today announced that it [...]
Menlo Therapeutics Announces Late-Breaking Oral Presentation at the American Academy of Dermatology Annual Meeting
29/01/2019
Results from the Phase 2 Clinical Trial of Serlopitant to Treat Pruritus with Psoriasis to be Presented on March 2, 2019 REDWOOD CITY, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a [...]
ProQR Announces “ProQR Vision 2023” Strategy at its Annual R&D Day
29/01/2019
LEIDEN, the Netherlands & CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines, today [...]
OLAH Healthcare Technology names Gregory Miller as Chief Executive Officer
29/01/2019
COLUMBUS, Ohio, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Tim Vogel, chairman of the Board of Directors of OLAH Healthcare Technology, announced the appointment of Gregory Miller as OLAH’s new chief executive officer effective [...]
Dr. Eric Simpson to Present Bermekimab Results in Atopic Dermatitis at 2019 AAD Annual Meeting
29/01/2019
Bermekimab Rapidly Treats Atopic Dermatitis While Reducing Itch and Pain AUSTIN, Texas, Jan. 29, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today that findings from its open label, multicenter study [...]
Extendicare Announces Timing of 2018 Fourth Quarter and Year End Results and Conference Call
29/01/2019
MARKHAM, Ontario, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the fourth quarter and year ended [...]
Momenta Pharmaceuticals Announces First Subject Dosed in Phase 1/2 Clinical Trial of M254, Hypersialylated Immunoglobulin G
29/01/2019
CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated [...]
Oryzon to present at upcoming international conferences
29/01/2019
21 st Annual BIO CEO & Investor Conference 2019 in New York, USA 12 th Annual European Life Sciences CEO Forum in Zurich, Switzerland 2019 BioCapital Europe in Amsterdam, The Netherlands 31 st Annual ROTH Conference [...]
Allakos Announces Positive Phase 2 Results in Patients with Cholinergic Urticaria and Symptomatic Dermographism
29/01/2019
-- 82% (9 of 11) response rate in patients with cholinergic urticaria -- -- 70% (7 of 10) response rate in patients with symptomatic dermographism -- REDWOOD CITY, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Allakos Inc [...]

Pages